Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 1.94% |
| 2 | Technology | 1.9% |
| 3 | Communication Services | 1.42% |
| 4 | Financials | 1.08% |
| 5 | Healthcare | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
CALL
BHP
BHP
$247B
| $64.9M | 0.01% |
999,259
-146,403
| -13% | -$9.68M |
|
1002
CALL
Edwards Lifesciences
EW
$52.2B
| $64.8M | 0.01% |
625,300
+334,500
| +115% | +$31.5M |
|
1003
CALL
iShares Russell 1000 Value ETF
IWD
$84.3B
| $64.7M | 0.01% |
407,800
-21,800
| -5% | -$3.45M |
|
1004
Kinder Morgan
KMI
$69B
| $64.6M | 0.01% |
3,541,412
-87,494
| -2% | -$1.56M |
|
1005
PUT
Yeti Holdings
YETI
$3.14B
| $64.5M | 0.01% |
702,600
+13,000
| +2% | +$1.13M |
|
1006
CALL
State Street SPDR S&P Retail ETF
XRT
$329M
| $64.5M | 0.01% |
663,000
-47,300
| -7% | -$4.42M |
|
1007
CALL
Hershey
HSY
$38.2B
| $64.4M | 0.01% |
369,900
+12,300
| +3% | +$2.07M |
|
|
GAP
1008
PUT
The Gap Inc
GAP
$7.33B
| $64.4M | 0.01% |
1,913,500
+403,800
| +27% | +$13.3M |
|
1009
CALL
Capri Holdings
CPRI
$1.55B
| $64.3M | 0.01% |
1,123,600
+343,600
| +44% | +$18.7M |
|
1010
CALL
Apollo Global Management
APO
$78.4B
| $64.2M | 0.01% |
1,032,900
-168,200
| -14% | -$9.33M |
|
1011
CALL
Boston Scientific
BSX
$71B
| $64.2M | 0.01% |
1,501,600
+303,700
| +25% | +$12.8M |
|
1012
CALL
CRISPR Therapeutics
CRSP
$5.52B
| $64M | 0.01% |
395,100
+57,900
| +17% | +$7.04M |
|
|
NXH
1013
PUT
Neighborhood Intelligence Inc
NXH
$372M
| $63.8M | 0.01% |
761,420
-115,500
| -13% | -$8.39M |
|
1014
PUT
Clover Health Investments
CLOV
$2.18B
| $63.8M | 0.01% |
4,788,600
+3,527,700
| +280% | +$34.6M |
|
1015
PUT
Appian
APPN
$2.81B
| $63.8M | 0.01% |
462,900
+66,900
| +17% | +$7.6M |
|
1016
CALL
Enterprise Products Partners
EPD
$82.8B
| $63.7M | 0.01% |
2,639,800
-554,900
| -17% | -$13.1M |
|
1017
CALL
Vipshop
VIPS
$6.88B
| $63.7M | 0.01% |
3,172,200
+1,635,200
| +106% | +$41.1M |
|
1018
CALL
International Flavors & Fragrances
IFF
$21.9B
| $63.6M | 0.01% |
425,700
+3,900
| +0.9% | +$560K |
|
1019
CALL
Estee Lauder
EL
$37.7B
| $63.5M | 0.01% |
199,700
+49,900
| +33% | +$15.1M |
|
1020
PUT
Dropbox
DBX
$7.58B
| $63.1M | 0.01% |
2,082,400
-222,600
| -10% | -$6.08M |
|
1021
Twilio
TWLO
$34.2B
| $63.1M | 0.01% |
160,028
-14,467
| -8% | -$5.02M |
|
1022
CALL
Tractor Supply
TSCO
$18.7B
| $63M | 0.01% |
1,692,000
-897,000
| -35% | -$32.9M |
|
1023
PUT
Analog Devices
ADI
$180B
| $62.8M | 0.01% |
364,800
+93,700
| +35% | +$15M |
|
1024
Blackrock
BLK
$182B
| $62.7M | 0.01% |
71,676
+40,113
| +127% | +$33.9M |
|
1025
TJX Companies
TJX
$155B
| $62.7M | 0.01% |
929,430
+234,416
| +34% | +$16M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,175 increased, 5,390 reduced and 1,328 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,328 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.